EU Backs Kinase Inhibitor Use in Initial Ph+ ALL Therapy

Iclusig, a kinase inhibitor, received a positive opinion for use alongside low-intensity chemotherapy in adults with newly identified disease. Medscape News Europe

Read the full article on medscape.com